Dosing equation for tacrolimus using genetic variants and clinical factors

Research output: Contribution to journalArticlepeer-review

113 Scopus citations

Abstract

Aim: To develop a dosing equation for tacrolimus, using genetic and clinical factors from a large cohort of kidney transplant recipients. Clinical factors and six genetic variants were screened for importance towards tacrolimus clearance (CL/F). Methods: Clinical data, tacrolimus troughs and corresponding doses were collected from 681 kidney transplant recipients in a multicentre observational study in the USA and Canada for the first 6months post transplant. The patients were genotyped for 2724 single nucleotide polymorphisms using a customized Affymetrix SNP chip. Clinical factors and the most important SNPs (rs776746, rs12114000, rs3734354, rs4926, rs3135506 and rs2608555) were analysed for their influence on tacrolimus CL/F. RESULTS The CYP3A5*1 genotype, days post transplant, age, transplant at a steroid sparing centre and calcium channel blocker (CCB) use significantly influenced tacrolimus CL/F. The final model describing CL/F (lh -1) was: 38.4 ×[(0.86, if days 6-10) or (0.71, if days 11-180)]×[(1.69, if CYP3A5*1/*3 genotype) or (2.00, if CYP3A5*1/*1 genotype)]× (0.70, if receiving a transplant at a steroid sparing centre) × ([age in years/50] -0.4) × (0.94, if CCB is present). The dose to achieve the desired trough is then prospectively determined using the individuals CL/F estimate. CONCLUSIONS The CYP3A5*1 genotype and four clinical factors were important for tacrolimus CL/F. An individualized dose is easily determined from the predicted CL/F. This study is important towards individualization of dosing in the clinical setting and may increase the number of patients achieving the target concentration. This equation requires validation in an independent cohort of kidney transplant recipients.

Original languageEnglish (US)
Pages (from-to)948-957
Number of pages10
JournalBritish Journal of Clinical Pharmacology
Volume72
Issue number6
DOIs
StatePublished - Dec 2011

Keywords

  • CYP3A5
  • Kidney transplantation
  • Pharmacogenetics
  • Pharmacogenomics
  • Pharmacokinetics
  • Tacrolimus

Fingerprint Dive into the research topics of 'Dosing equation for tacrolimus using genetic variants and clinical factors'. Together they form a unique fingerprint.

Cite this